Cancer Genetic Testing in Ethnic Populations
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Carcinoma of Unknown Primary
- Breast Carcinoma
- Central Nervous System Carcinoma
- Digestive System Carcinoma
- Genitourinary System Carcinoma
- Head and Neck Carcinoma
- Malignant Brain Neoplasm
- Malignant Female Reproductive System Neoplasm
- Malignant Musculoskeletal Neoplasm
- Malignant Solid Neoplasm
- Skin Carcinoma
- Type
- Observational
- Design
- Observational Model: Case-OnlyTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
PRIMARY OBJECTIVE: I. To determine the prevalence of genetic mutations in cancer patients from various ethnic populations seeking care at Mayo Clinic Arizona cancer clinics. SECONDARY OBJECTIVES: I. Perform a chart review to assess the impact of genetic testing as part of standard of oncology care: ...
PRIMARY OBJECTIVE: I. To determine the prevalence of genetic mutations in cancer patients from various ethnic populations seeking care at Mayo Clinic Arizona cancer clinics. SECONDARY OBJECTIVES: I. Perform a chart review to assess the impact of genetic testing as part of standard of oncology care: Ia. Determine prevalence of pathogenic germline mutation detected by multi-gene panel testing. Ib. Determine differences in germline mutation detection in these patients as compared to traditional guideline (National Comprehensive Cancer Network [NCCN]) based approach for genetic evaluation. OUTLINE: Patients undergo collection of blood or saliva sample for genetic testing.
Tracking Information
- NCT #
- NCT04475640
- Collaborators
- National Cancer Institute (NCI)
- Investigators
- Principal Investigator: Niloy J Samadder Mayo Clinic
Get Well Soon